Evidence review · standard

cjc 1295

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `cjc-1295`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/cjc-1295

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/cjc-1295/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/cjc-1295/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/cjc-1295/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/cjc-1295/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: Growth-hormone secretagogues are studied for metabolic and tissue maintenance pathways — anabolic/regenerative signaling vs age-related decline.

What it is

2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.

How it works

From preclinical claims (animal/lab — not human proof):

  1. 2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.

Why it would work (logic chain)

  1. IF 2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 0 anecdote source(s) (posts, threads, comments)
  • 0 anecdote-tier claim(s) derived from them

Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 1
  • Claims tagged human evidence: 0
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 1

Logic: Studies exist in the ledger, but none are graded as strong human proof for the uses people discuss online. Animal and lab work is not the same as proof in people.

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.07 / 1.00 — very low

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians (source s1)

2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Cjc 1295 · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
Evidence · 1 sources · swipe →chain 26a00f5442b8 · verify chain · provenance
Evidence ledger 1 · tier-ranked · API
preclinical
2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.
sources: s1
Model swipes · 2 from 1 model · swipe →verify
1 / 2
grok-4.3writer
draft2026-06-29 17:03
cjc 1295
inspect — what it was prompted & output
prompted with
(default writer prompt)
74e51f4b4eefb3cf
grok-4.3source_hunt
sources2026-06-29 17:04
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: cjc-1295
it output
1 source(s) added
27e9775dad899720
Ask this article · 3 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emp…"?
ask cjc-1295 claim c1 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about cjc 1295 — and what would you need me to tell you first?
ask cjc-1295 condition gaps · paste includes §SELF
What good and bad outcomes are documented for cjc 1295 (studies vs anecdotes)?
ask cjc-1295 good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →